The 2017 TSX Composite Compensation & Performance Report is available for purchase here.
Some major shareholders are growing frustrated with the way companies are doling out share units as a major part of CEO pay, voting against pay packages at several large companies this year over concerns about equity grants that are oversized or poorly linked to performance.Report Typo/Error
- Valeant Pharmaceuticals International Inc$18.13+0.10(+0.55%)
- Valeant Pharmaceuticals International Inc$14.41+0.06(+0.42%)
- Eldorado Gold Corp$2.39+0.02(+0.84%)
- Eldorado Gold Corp$1.90+0.00(+0.26%)
- Encana Corp$11.44+0.03(+0.26%)
- Encana Corp$9.10+0.01(+0.11%)
- Updated August 23 9:59 AM EDT. Delayed by at least 15 minutes.